Psychosocial Needs Remain Largely Unmet for Patients with Lung Cancer, Caregivers
Leah LawrenceThere is a critical need for psychosocial services in the lung cancer care pathway, according to a presentation by Anne-Marie Baird, BS, PhD, on behalf of Lung Cancer Europe (LUCE), […] Read more
Studies Question Further Modification of pTNM Staging as 9th Edition Deadline Approaches
Leah LawrenceTwo studies presented at the WCLC Congress 2021 include data that suggest the potential need to update the current TNM classification of lung cancers by implementing additional pathological elements to […] Read more
In 2015, the World Health Organization (WHO) revised its 2004 classification of lung tumors to reflect the impact of genetic, clinical, and radiologic advances in the field.1 Among the revisions […] Read more
Assay that Combines Clinical, Radiomic Characteristics with CT Information Shown to Better Distinguish Malignant Early Lung Nodules
Beth Fand IncollingoAlthough low-dose CT scans enable the detection of very small lung nodules in individuals who face a high risk of developing lung cancer, it is often impossible to quickly determine […] Read more
Surgical resection remains the gold standard for patients diagnosed with early-stage lung cancer, and since the early 1990s, video-assisted thoracoscopic surgery (VATS) lobectomy has been acknowledged as an effective – […] Read more
Surgical Outcomes of CheckMate816 Support Use of Neoadjuvant Nivolumab Plus Chemotherapy for NSCLC
Leah LawrencePatients treated with neoadjuvant combination nivolumab plus chemotherapy who had resectable NSCLC underwent surgical resection at similar rates and timeframes to those undergoing neoadjuvant chemotherapy, according to a presentation of […] Read more
VIOLET Data Establishes VATS as Standard for Early-Stage Resectable NSCLC
Leah LawrenceA presentation of updated results from the VIOLET study comparing video-assisted thoracoscopic surgery (VATS) with open lobectomy showed that improvements in pain, in-hospital complications, and shorter hospital stay previously reported […] Read more
High-Dose Once-Daily Thoracic Radiotherapy Did Not Improve OS in Limited Stage SCLC
Leah LawrenceHigh-dose 70 Gy once-daily thoracic radiotherapy did not significantly improve OS compared with the current standard of 45 Gy twice-daily radiotherapy in patients with limited-stage SCLC, according to results of […] Read more
Single Institution’s Experience: SABR Shows Outstanding OS vs. VATS in Patients with Early-Stage NSCLC
Leah LawrenceTreatment of operable, stage-I NSCLC with stereotactic ablative radiotherapy (SABR) was noninferior to video-assisted thoracic surgery (VATS) with mediastinal lymph node dissection (L-MLND). Joseph Y. Chang, MD, of The University […] Read more
IMpower010: Adjuvant Atezolizumab Improved DFS in PD-L1 Expressing Stage II-IIIA NSCLC
Leah LawrenceAdjuvant atezolizumab significantly improved disease-free survival (DFS) compared with best supportive care after chemotherapy in patients with resected stage II-IIIA NSCLC, according to the results of the IMpower010 study presented […] Read more